Stockscreener 앱 받기
0.00
100.00%
-6.81
전일 마감가:
$6.81
열려 있는:
$0
하루 거래량:
0
Relative Volume:
0.00
시가총액:
$15.86M
수익:
-
순이익/손실:
$-67.28M
주가수익비율:
0.00
EPS:
-94.66
순현금흐름:
$-9.80M
1주 성능:
-100.00%
1개월 성능:
-100.00%
6개월 성능:
-100.00%
1년 성능:
-100.00%
1일 변동 폭
$0.00
$0.00
1주일 범위
$0.00
$0.00
52주 변동 폭
$0.00
$15.82
Portage Biotech Inc Stock (PRTG) Company Profile
PRTG을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
PRTG
Portage Biotech Inc
|
0.00 | 15.86M | 0 | -67.28M | -9.80M | -94.66 |
|
VRTX
Vertex Pharmaceuticals Inc
|
443.01 | 115.56B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
707.41 | 75.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
431.37 | 60.52B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
910.17 | 55.48B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
199.39 | 43.51B | 447.02M | -1.18B | -906.14M | -6.1812 |
Portage Biotech Inc Stock (PRTG) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2022-07-18 | 재개 | Oppenheimer | Outperform |
| 2022-03-07 | 개시 | H.C. Wainwright | Buy |
| 2021-09-21 | 개시 | Oppenheimer | Outperform |
| 2021-09-02 | 개시 | B. Riley Securities | Buy |
| 2021-08-19 | 개시 | Cantor Fitzgerald | Overweight |
Portage Biotech Inc 주식(PRTG)의 최신 뉴스
AlphaTON Capital to Reveal 2026 Technical Strategy in Landmark Inaugural AMA Event - marketscreener.com
AlphaTON Capital Exits SEC “Baby-Shelf Rules” and Files $420.69 Million Shelf Registration Statement - markets.businessinsider.com
Why Portage Biotech Inc. stock is a value investor pickTrade Entry Report & Free Low Drawdown Momentum Trade Ideas - Newser
Will Portage Biotech Inc. stock beat EPS estimatesJuly 2025 Opening Moves & Low Risk Entry Point Guides - Newser
Can Portage Biotech Inc. stock beat market expectations this quarterPortfolio Performance Report & Intraday High Probability Alerts - BỘ NỘI VỤ
Is Portage Biotech Inc. stock overvalued by current metricsEarnings Miss & AI Enhanced Trading Alerts - BỘ NỘI VỤ
Form 6-KReport of foreign issuer [Rules 13a-16 and 15d-16] - ADVFN
Portage Biotech Reports Results for Fiscal Year Ended March 31, 2025 - ADVFN
AlphaTON Capital Initiates $15.3M ATM Offering - TipRanks
Portage Biotech Stock Surges On New Preclinical Data In Mesothelioma Trial: Retail Gets More Bullish - MSN
ATON launches $15.3M at-the-market ordinary share program - Stock Titan
AlphaTON Capital Clarifies Equity Line and Expands Strategic Initiatives - The Globe and Mail
Portage Biotech’s After-Hours Surge On Preclinical Tumor Trial Data Sends Retail Optimism Sky-High - MSN
Why analysts upgrade Portage Biotech Inc. stockQuarterly Growth Report & Low Drawdown Trading Strategies - newser.com
AlphaTON Bolsters Tech Leadership with New CTO to Drive AI Growth - markets.businessinsider.com
Will Portage Biotech Inc. stock outperform growth indexesTrade Exit Summary & Safe Entry Zone Identification - newser.com
How to integrate Portage Biotech Inc. into portfolio analysis tools2025 Market Outlook & Low Drawdown Momentum Trade Ideas - newser.com
Published on: 2025-11-19 21:57:05 - newser.com
Analyzing Portage Biotech Inc. with multi timeframe chartsEarnings Overview Summary & Weekly Top Stock Performers List - newser.com
How sentiment analysis helps forecast Portage Biotech Inc.Insider Selling & Weekly Top Gainers Trade List - newser.com
AlphaTON Capital (Nasdaq: ATON) Issues Shareholder Update - GlobeNewswire
Published on: 2025-11-19 04:22:07 - newser.com
Is Portage Biotech Inc. stock a dividend growth opportunityWeekly Stock Recap & Technical Buy Zone Confirmations - newser.com
What makes Portage Biotech Inc. stock attractive to growth fundsWall Street Watch & Low Risk High Reward Ideas - newser.com
Using R and stats models for Portage Biotech Inc. forecastingGDP Growth & Verified High Yield Trade Plans - newser.com
Is Portage Biotech Inc. stock entering bullish territoryQuarterly Earnings Summary & Community Consensus Stock Picks - newser.com
AlphaTON Capital Selects P2P.org as First Institutional Staking Partner for TON Treasury Operations - markets.businessinsider.com
Regression analysis insights on Portage Biotech Inc. performance2025 Dividend Review & Verified Entry Point Signals - newser.com
Momentum divergence signals in Portage Biotech Inc. chartTrade Risk Summary & Technical Pattern Alert System - newser.com
How Portage Biotech Inc. stock benefits from tech adoptionQuarterly Market Review & Stepwise Trade Execution Plans - newser.com
Published on: 2025-11-16 04:36:16 - newser.com
Published on: 2025-11-16 01:54:11 - newser.com
Is a relief rally coming for Portage Biotech Inc. holdersEarnings Miss & Community Supported Trade Ideas - newser.com
Is this a good reentry point in Portage Biotech Inc.Earnings Recap Summary & Short-Term High Return Strategies - newser.com
Portage Biotech Inc (PRTG) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.94%
0.33%
자본화:
|
볼륨(24시간):